These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Thalidomide pros and cons. Am J Nurs; 1998 Apr; 98(4):63. PubMed ID: 9556688 [No Abstract] [Full Text] [Related]
23. Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: case report and review. Ball SC; Sepkowitz KA; Jacobs JL Am J Gastroenterol; 1997 Jan; 92(1):169-70. PubMed ID: 8995965 [No Abstract] [Full Text] [Related]
24. Thalidomide for mouth ulcers and wasting. Baker R BETA; 1995 Dec; ():8. PubMed ID: 11363016 [TBL] [Abstract][Full Text] [Related]
26. Aphtous stomatitis in a patient with Behçet's disease and HIV was associated with an increased HIV load. Mercié P; Viallard JF; Cipriano C; Tchamgoué S; Leng B; Pellegrin JL Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S54. PubMed ID: 12371637 [No Abstract] [Full Text] [Related]
27. Treatment for weight loss, tuberculosis and AIDS? Treat Rev; 1995 Nov; (no 20):4. PubMed ID: 11363021 [TBL] [Abstract][Full Text] [Related]
28. Thalidomide treatment of mucosal ulcerations in HIV infection. Harry TC Arch Dis Child; 1996 Jul; 75(1):90. PubMed ID: 8813889 [No Abstract] [Full Text] [Related]
29. Thalidomide treatment of mucosal ulcerations in HIV infection. Solèr RA; Migliorati C; van Waes H; Nadal D Arch Dis Child; 1996 Jan; 74(1):64-5. PubMed ID: 8660053 [TBL] [Abstract][Full Text] [Related]
30. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Revuz J; Guillaume JC; Janier M; Hans P; Marchand C; Souteyrand P; Bonnetblanc JM; Claudy A; Dallac S; Klene C Arch Dermatol; 1990 Jul; 126(7):923-7. PubMed ID: 2193629 [TBL] [Abstract][Full Text] [Related]
31. Thalidomide: an alternative therapy for treatment of apthous ulcers (canker sores). Manesis DA STEP Perspect; 1995; 7(1):16-7. PubMed ID: 11362397 [TBL] [Abstract][Full Text] [Related]
32. Thalidomide heals HIV-related oral ulcers, but caution is required. Am J Health Syst Pharm; 1997 Jul; 54(13):1485-6. PubMed ID: 9217937 [No Abstract] [Full Text] [Related]
33. Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations. Shetty K Gen Dent; 2007; 55(6):537-42. PubMed ID: 18050580 [TBL] [Abstract][Full Text] [Related]
34. [Oral ulcers in HIV infection]. Bassetti S; Courvoisier S; Itin P Praxis (Bern 1994); 1997 May; 86(21):912-3. PubMed ID: 9244978 [No Abstract] [Full Text] [Related]
35. Recurrent aphthous ulcer in patient infected with human immunodeficiency virus: successful treatment with thalidomide. Radeff B; Kuffer R; Samson J J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):523-5. PubMed ID: 2212162 [No Abstract] [Full Text] [Related]
36. [Treatment of recurrent aphthae with thalidomide in patients with acquired immunodeficiency syndrome]. Tercedor J; Ortego N; Ródenas JM; Hernández J Med Clin (Barc); 1991 Jun; 97(2):79. PubMed ID: 1895795 [No Abstract] [Full Text] [Related]
37. Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations. Günzler V Drug Saf; 1992; 7(2):116-34. PubMed ID: 1605898 [TBL] [Abstract][Full Text] [Related]
38. Thalidomide use is associated with weight gain in HIV-1-positive clients. Sharp M; Getty J; Klausner JD J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):392. PubMed ID: 9342262 [No Abstract] [Full Text] [Related]